CN101217937A - 包含奥洛他定的透皮吸收眼科制剂 - Google Patents

包含奥洛他定的透皮吸收眼科制剂 Download PDF

Info

Publication number
CN101217937A
CN101217937A CNA2006800248918A CN200680024891A CN101217937A CN 101217937 A CN101217937 A CN 101217937A CN A2006800248918 A CNA2006800248918 A CN A2006800248918A CN 200680024891 A CN200680024891 A CN 200680024891A CN 101217937 A CN101217937 A CN 101217937A
Authority
CN
China
Prior art keywords
olopatadine
eye
formulation
acid
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800248918A
Other languages
English (en)
Chinese (zh)
Inventor
礒脇明治
中岛朋子
大鸟聪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of CN101217937A publication Critical patent/CN101217937A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2006800248918A 2005-07-08 2006-07-07 包含奥洛他定的透皮吸收眼科制剂 Pending CN101217937A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69736805P 2005-07-08 2005-07-08
US60/697,368 2005-07-08

Publications (1)

Publication Number Publication Date
CN101217937A true CN101217937A (zh) 2008-07-09

Family

ID=37022903

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800248918A Pending CN101217937A (zh) 2005-07-08 2006-07-07 包含奥洛他定的透皮吸收眼科制剂

Country Status (7)

Country Link
US (1) US8101654B2 (https=)
EP (1) EP1901708B1 (https=)
JP (1) JP5315051B2 (https=)
KR (1) KR20080038335A (https=)
CN (1) CN101217937A (https=)
ES (1) ES2437077T3 (https=)
WO (1) WO2007007863A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106324111A (zh) * 2015-06-24 2017-01-11 江苏吉贝尔药业股份有限公司 一种盐酸奥洛他定滴眼液的检测方法
CN107823124A (zh) * 2017-11-09 2018-03-23 广州博济医药生物技术股份有限公司 一种盐酸奥洛他定外用组合物及其乳膏剂

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
CN101217948A (zh) * 2005-07-08 2008-07-09 千寿制药株式会社 包含依匹那丁的透皮吸收眼科制剂
EP2056809A1 (en) * 2006-08-28 2009-05-13 Senju Pharmaceutical Co., Ltd. Ophthalmic percutaneous absorption type preparation
US9034830B2 (en) 2009-10-30 2015-05-19 Intratus, Inc. Methods and compositions for sustained delivery of drugs
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
BR112015014367B1 (pt) * 2012-12-19 2022-11-22 Novartis Ag Composição inibidora de lfa-1, método para estabilizar a dita composição e uso da mesma para tratar uma doença ocular
TW201705956A (zh) * 2015-05-12 2017-02-16 參天製藥股份有限公司 唑系抗真菌藥之對眼瞼皮膚的投與
TWI825013B (zh) * 2017-04-19 2023-12-11 日商帝國製藥股份有限公司 含有盧帕他定（ｒｕｐａｔａｄｉｎｅ）之貼附劑

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
CA2225808C (en) * 1995-06-30 2002-12-17 Christopher C. Capelli Silver-based pharmaceutical compositions
JPH09194396A (ja) * 1996-01-17 1997-07-29 Pola Chem Ind Inc 貼付剤用マトリックス
EP1187617B1 (en) * 1999-06-18 2004-03-03 Alcon Manufacturing Ltd. Method for selecting the concentration of an amphipathic antihistamine drug by determining the drug's surface activity rating
KR100686527B1 (ko) * 1999-07-15 2007-02-27 히사미쓰 세이야꾸 가부시키가이샤 경피흡수제제
JP4653893B2 (ja) * 2000-01-27 2011-03-16 純一 須藤 二層型経皮吸収製剤
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
KR20050092429A (ko) 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106324111A (zh) * 2015-06-24 2017-01-11 江苏吉贝尔药业股份有限公司 一种盐酸奥洛他定滴眼液的检测方法
CN107823124A (zh) * 2017-11-09 2018-03-23 广州博济医药生物技术股份有限公司 一种盐酸奥洛他定外用组合物及其乳膏剂
CN107823124B (zh) * 2017-11-09 2018-11-27 广州博济医药生物技术股份有限公司 一种盐酸奥洛他定外用组合物及其乳膏剂

Also Published As

Publication number Publication date
US20090209632A1 (en) 2009-08-20
ES2437077T3 (es) 2014-01-08
EP1901708A1 (en) 2008-03-26
WO2007007863A1 (en) 2007-01-18
EP1901708B1 (en) 2013-09-11
JP5315051B2 (ja) 2013-10-16
US8101654B2 (en) 2012-01-24
KR20080038335A (ko) 2008-05-06
JP2009500398A (ja) 2009-01-08

Similar Documents

Publication Publication Date Title
JP5020061B2 (ja) 経皮吸収型製剤
JP4629578B2 (ja) 眼疾患治療用経皮吸収型製剤
RS59483B1 (sr) Postupci i kompozicije za neprekidno oslobađanje lekova
US20090318422A1 (en) Ophthalmic percutaneous absorption type preparation
TW201130935A (en) Transdermally absorbed preparation of anti-dementia drug
EP1754491B1 (en) Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist
CN101217937A (zh) 包含奥洛他定的透皮吸收眼科制剂
US11179345B2 (en) Water-based adhesive patch
CN101217948A (zh) 包含依匹那丁的透皮吸收眼科制剂
TW201717920A (zh) 經皮吸收型製劑
US20250000814A1 (en) Percutaneous absorption preparation for treating dementia comprising memantine enanthate
JP6729584B2 (ja) 経皮吸収型貼付剤
JP6695571B2 (ja) 経皮吸収型製剤
WO2005102306A1 (ja) 消炎鎮痛貼付剤
TW201002313A (en) Antipruritic and analgesic medicine containing oxybuprocaine for external use
JP2004307364A (ja) 経皮吸収貼付剤
KR20070018755A (ko) 무스카린 수용체 작동약을 함유한 안과용 경피흡수형 제제
EP1917964A1 (en) Percutaneously absorbable ophthalmic preparation
JP2016216384A (ja) 経皮吸収型製剤
JP2017007994A (ja) 経皮吸収型製剤
HK1137344A1 (en) Tape preparation
HK1137344B (en) Tape preparation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20080709

RJ01 Rejection of invention patent application after publication